Grong Sparebank (OSL:GRONG)

Norway flag Norway · Delayed Price · Currency is NOK
153.98
-0.02 (-0.01%)
At close: Aug 1, 2025

Verve Therapeutics Cash Flow Statement

Millions NOK. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 20202016 - 2020
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2016 - 2020
Net Income
-111.07155.22165.7185.8787.4
Upgrade
Depreciation & Amortization
-62.5551.3342.1633.8225.47
Upgrade
Other Operating Activities
--322.07-161.22132.35-339.99-123.12
Upgrade
Operating Cash Flow
--148.4545.33340.23-220.29-10.25
Upgrade
Operating Cash Flow Growth
---86.68%---
Upgrade
Capital Expenditures
--1.86-1.78-0.84-1.79-0.3
Upgrade
Sale of Property, Plant and Equipment
--0.760.210.2830.03
Upgrade
Investment in Securities
--38.15-28.19-106.27-25.3-77.85
Upgrade
Other Investing Activities
-12.1518.0624.0816.7616.53
Upgrade
Investing Cash Flow
--27.85-11.15-82.82-10.05-31.6
Upgrade
Long-Term Debt Issued
-600230225375.72280.33
Upgrade
Long-Term Debt Repaid
--325.67-150.66-475.13-175-290
Upgrade
Net Debt Issued (Repaid)
-274.3479.34-250.13200.72-9.67
Upgrade
Issuance of Common Stock
---104.13--
Upgrade
Common Dividends Paid
--39.73-35.75-26.75-17.84-20.81
Upgrade
Other Financing Activities
-0.71-10.61-6.95-5.72-26.49
Upgrade
Financing Cash Flow
-235.3232.98-179.71177.17-56.96
Upgrade
Net Cash Flow
-59.0267.1677.7-53.18-98.8
Upgrade
Free Cash Flow
--150.343.55339.39-222.08-10.55
Upgrade
Free Cash Flow Growth
---87.17%---
Upgrade
Free Cash Flow Margin
--48.21%12.37%105.91%-99.18%-5.15%
Upgrade
Free Cash Flow Per Share
--37.8410.9698.09-74.71-3.55
Upgrade
Cash Interest Paid
-362.12264.39104.5845.2373.9
Upgrade
Cash Income Tax Paid
-32.3523.6322.9819.1818.2
Upgrade
Updated Mar 19, 2025. Source: S&P Global Market Intelligence. Banks template. Financial Sources.